Intra‐arterial 5‐fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases

Yoshio Katamura(Hiroshima University), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Akira Hiramatsu(Hiroshima University), Tomokazu Kawaoka(Hiroshima University), Hiroshi Aikata(Hiroshima Prefectural Hospital), M. Ishikawa(Kazusa DNA Research Institute), Masashi Hieda(Hiroshima University), Hideaki Kakizawa(Hiroshima University), Shoichi Takahashi(Hiroshima University), Shintaro Takaki(Frontier Science Foundation), Yuki Kimura(Jichi Medical University), Yoshiiku Kawakami(Hiroshima University Hospital), Koji Waki(Frontier Science Foundation)
Journal of Gastroenterology and Hepatology
January 14, 2010
10.1111/j.1440-1746.2009.06110.x
Cited by 17

Related Papers

A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells
|Cell stem cell|2010|670
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance
|Immunity|2001|594